Benjamin Edwards Inc Amgen Inc Transaction History

Benjamin Edwards Inc

$503 Million
Q1 2024

A detailed history of Benjamin Edwards Inc transactions in Amgen Inc stock. As of the latest transaction made, Benjamin Edwards Inc holds 5,785 shares of AMGN stock, worth $1.83 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

5,785

Previous 4,230 36.76%

Holding current value

$1.83 Million

Previous $1.22 Million 35.06%

% of portfolio

0.33%

Previous 0.27%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $418,092 - $504,690	1,555 Added 36.76%	5,785 $1.65 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $20,711 - $23,365	-81 Reduced 1.88%	4,230 $1.22 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $3,935 - $4,886	-18 Reduced 0.42%	4,311 $1.16 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $648,166 - $766,444	3,025 Added 231.98%	4,329 $961,000
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $369,618 - $450,502	-1,637 Reduced 55.66%	1,304 $315,000

Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $21,070 - $26,772	-92 Reduced 3.03%	2,941 $772,000
Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $133,104 - $150,117	-593 Reduced 16.35%	3,033 $684,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $318,610 - $354,557	1,381 Added 61.51%	3,626 $882,000
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $136,605 - $151,121	623 Added 38.41%	2,245 $543,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $319,003 - $365,070	1,604 Added 8911.11%	1,622 $365,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $197 - $242	1 Added 5.88%	18 $4,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $3,216 - $4,134	-17 Reduced 50.0%	17 $4,000
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $5,667 - $6,643	34 New	34 $6,000

Others Institutions Holding AMGN

# of Institutions

2,936

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Amgen Inc Transaction History